Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID): a National Platform Trial

NCT04801940 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT04801940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04801940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID): a National Platform Trial
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Phase
Phase 3
Overall status
Unknown status
Start date
May 19, 2021
Completion date
January 31, 2024
Enrollment
2,631 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19